Drawing for VIN-VETINNOVATIONS

USPTO serial 79227779

VIN-VETINNOVATIONS

Reviewed by CopyMark Law Group

Reg. 5815729Status 709
Filing date
Status date
Registration date
Jul 30, 2019
Examiner
MAHONEY, PAULA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIN-VETINNOVATIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anne E. Naffziger

Anne E. Naffziger Leydig, Voit & Mayter, Ltd.1981 N. Broadway, Suite 310Walnut Creek, CA 94596UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Shampoos for pets; cosmetics for pets; shampoos for animals; breath fresheners for animals; cosmetics for animals; deodorants for animals; skin care products for animals, namely, non-medicated lotions, non-medicated creams, non-medicated foams, non- medicated sprays or non-medicated powders; odour fresheners for animals; non-medicated bath preparations for animals; non-medicated sprays for animals for conditioning and/or moisturizing and/or deodorizing of fur or skin; non-medicated preparations and products for fur care, namely, sprays, lotions, creams, foams and shampoos; non-medicated dental care preparations for animals, namely, namely toothpastes, dental sprays, cleaning gels; preparations for toiletry and beauty care for animals, namely, non-medicated shampoos, non-medicated soaps, non-medicated sprays, non-medicated powders and non- medicated foamsSECTION 71 - CANCELLED—
005Animal dip preparations, namely, bath preparations containing insect repellents for immersing animals to control or to repel ticks, flies, mosquitos, mites and lice and other animal parasites; dietary supplements for animals; medicines for veterinary purposes for the treatment of local or topical infections, arthritis, neurodermitis or other inflammatory skin conditions; neutraceutical preparations for animals for the treatment of arthritis, neurodermitis or other inflammatory conditions; food additives for animals for medical purposes, namely, elementary silver, emulsifiers, stabilizers, in particular lecithin, substances for preventing food decay or deterioration; antibiotic food supplements for animals; pharmaceutical preparations for animals for treating local or topical infections, arthritis, neurodermitis or other inflammatory skin conditions; medicated supplements for animal foodstuffs; nutritional supplements for veterinary use; dietary supplement preparations of trace elements preparations for use by animals to enhance bone growth or reproduction, to improve wound healing, muscle function and nerve function and to improve fur; dietetic food adapted for veterinary use; medicated skin lotions, sprays, foams, creams and powders for treatment of animal's skin, fur, hair, paws and mouth; pharmaceutical preparations for animal skincare; powders for killing fleas on animals; dietary supplement preparations of trace elements for consumption by animals, namely, preparations comprising potassium, calcium, magnesium, sodium, phosphorous, boron, chrome, iron, fluorine, iodine, copper, manganese, molybdenum, selenium, vanadium, zinc and/or silver; nutritional additives to foodstuffs for animals, for medical purposes, namely, neutraceutical preparations for the treatment of arthritis, neurodermitis or other inflammatory conditions, probiotics to enhance rumen functions, minerals or trace elements to enhance bone growth or to improve muscle and nerve function, wound healing or reproduction and fibres to protect against colorectal diseases; pharmaceutical implants for animals, namely, implantable drug delivery devices, ports, stents, bone cements or hernia meshes filled or equipped with antibiotics, anti- inflammatory pharmaceuticals, pain killers, blood pressure drugs, or substances that affect blood clotting, enhance biocompatibility or promote wound healing or substances that modify or regulate the immune response and provide relief against insect-bites and implants comprising living cells or tissues for improving tissue regeneration; pharmaceutical implants for animals, namely antibacterial coated implants comprising living tissue for replacement of bones or joints; implants comprising a biocompatible coated scaffold material for guided tissue regeneration in animals; pharmaceutical preparations for the relief of insect bites on animals; pharmaceutical sprays for the relief of insect bites on animals; insect repellents for animals; anti-insect spray for animals; pharmaceutical preparations for wound treatment of animals; pharmaceutical sprays and creams for wound treatment of animals; medical dressings for animals; pharmaceutical preparations for animal wounds; wound dressings for animals; vulnerary sponges for animals; sponge material for healing wounds in animals, namely a hydrogel impregnated sponge; antiseptic preparations for animal wound care; preparations for neutralizing of animal odours for use on hair, fur, textiles or carpets; odour neutralizing preparations for textiles and other objects animals get in contact with, namely, blankets, dog baskets, cat baskets or leashesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 13, 2026C71TCANCELLED SECTION 71—
Jul 30, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 6, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 16, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 16, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 17, 2019GPNXNOTIFICATION PROCESSED BY IB—
May 14, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 14, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 1, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 24, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 30, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 29, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 28, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 15, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 11, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 19, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2018RFNTREFUSAL PROCESSED BY IB—
Mar 22, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 22, 2018RFRRREFUSAL PROCESSED BY MPU—
Mar 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 5, 2018DOCKASSIGNED TO EXAMINER—
Mar 5, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance